Center for Scientific Review; Notice of Closed Meetings, 2914-2915 [2011-871]
Download as PDF
2914
Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended,
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Eye Institute, including
consideration of personnel
qualifications and performances, and
the competence of individual
investigators, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSKH9S0YB1PROD with NOTICES
Name of Committee: Board of Scientific
Counselors, National Eye Institute.
Date: February 27–March 1, 2011.
Time: 7 a.m. to 5 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Sheldon S. Miller, PhD,
Scientific Director, National Institutes of
Health, National Eye Institute, Bethesda, MD
20892, (301) 451–6763.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information will be posted when
available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: January 11, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–880 Filed 1–14–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:24 Jan 14, 2011
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; PSI Materials Repository Review.
Date: February 11, 2011.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3AN18, Bethesda, MD 20892. (Telephone
Conference Call.)
Contact Person: Brian R. Pike, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18K, Bethesda,
MD 20892, 301–594–3907,
pikbr@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: January 11, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–877 Filed 1–14–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board, February 7, 2011, 6:30
Jkt 223001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
p.m. to February 9, 2011, 12 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Bethesda, MD
20892 which was published in the
Federal Register on December 29, 2010,
75 FR 82035.
This notice is being amended to
cancel the Subcommittee on Clinical
Investigations meeting on February 7,
2011 from 6:30 p.m. to 8 p.m. and to
cancel the National Cancer Advisory
Board Meeting on February 9, 2011 from
9 a.m. to 12 p.m. The meeting will be
open to the public on February 8, 2011
from 9 a.m. to 3:15 p.m. and the closed
session will be from 3:30 p.m. to 5 p.m.
The meeting is partially closed to the
public.
Dated: January 11, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–872 Filed 1–14–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Oral Microbiology.
Date: January 27–28, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Baljit S. Moonga, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7806, Bethesda, MD 20892, 301–435–
1777, moongabs@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\18JAN1.SGM
18JAN1
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Risk Prevention and Health
Behavior.
Date: February 2, 2011.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: Claire E. Gutkin, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106,
MSC 7808, Bethesda, MD 20892, 301–594–
3139, gutkincl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Molecular
Neuropharmacology and Signaling Study
Section.
Date: February 7–8, 2011.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Deborah L. Lewis, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–408–
9129, lewisdeb@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Development and Disease
Study Section.
Date: February 9–10, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina, 530 West Pico
Boulevard, Santa Monica, CA 90405.
Contact Person: Priscilla B. Chen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4104,
MSC 7814, Bethesda, MD 20892, (301) 435–
1787. chenp@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Neurodegeneration Study Section.
Date: February 9–10, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 501 Geary Street, San
Francisco, CA 94102.
Contact Person: Laurent Taupenot, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–435–
1203. taupenol@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Innate Immunity
and Inflammation Study Section.
Date: February 10–11, 2011.
VerDate Mar<15>2010
16:24 Jan 14, 2011
Jkt 223001
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites Santa
Monica Hotel, 1707 Fourth Street, Santa
Monica, CA 90401.
Contact Person: Tina McIntyre, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892. 301–594–
6375. mcintyrt@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Host Interactions with Bacterial Pathogens
Study Section.
Date: February 11, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Hotel, 13534 Bali
Way, Marina del Rey, CA 90292.
Contact Person: Fouad A El-Zaatari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892. (301) 435–
1149. elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR08–130:
International Research in Infectious Diseases
including AIDS (IRIDA).
Date: February 11, 2011.
Time: 1 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Hotel, 1354 Bali
Way, Marina del Rey, CA 90292.
Contact Person: Soheyla Saadi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892. 301–435–
0903. saadisoh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative: Cardiovascular Disease and
Epidemiology.
Date: February 11, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: J Scott Osborne, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4114,
MSC 7816, Bethesda, MD 20892. (301) 435–
1782. osbornes@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 11, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–871 Filed 1–14–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
2915
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2010–0087]
RIN 1601–ZA09
Identification of Foreign Countries
Whose Nationals Are Eligible To
Participate in the H–2A and H–2B
Nonimmigrant Worker Programs
Office of the Secretary, DHS.
Notice.
AGENCY:
ACTION:
Under Department of
Homeland Security (DHS) regulations,
U.S. Citizenship and Immigration
Services (USCIS) may approve petitions
for H–2A and H–2B nonimmigrant
status only for nationals of countries
that the Secretary of Homeland Security,
with the concurrence of the Secretary of
State, has designated by notice
published in the Federal Register. That
notice must be renewed each year. This
notice announces that the Secretary of
Homeland Security, in consultation
with the Secretary of State, is
identifying 53 countries whose
nationals are eligible to participate in
the H–2A and H–2B programs for the
coming year.
DATES: Effective Date: This notice is
effective January 18, 2011, and shall be
without effect at the end of one year
after January 18, 2011.
FOR FURTHER INFORMATION CONTACT:
Alexander Hartman, Office of Policy,
Department of Homeland Security,
Washington, DC 20528, (202) 282–9820.
SUPPLEMENTARY INFORMATION:
Background: USCIS generally may
approve H–2A and H–2B petitions only
for nationals of countries that the
Secretary of Homeland Security, with
the concurrence of the Secretary of
State, has designated as participating
countries. Such designation must be
published as a notice in the Federal
Register and expires after one year.
USCIS may, however, allow a national
from a country not on the list to be
named as a beneficiary of an H–2A or
H–2B petition based on a determination
that such participation is in the U.S.
interest. See 8 CFR 214.2(h)(5)(i)(F) and
8 CFR 214.2(h)(6)(i)(E).
In designating countries to include on
the list, the Secretary of Homeland
Security, with the concurrence of the
Secretary of State, will take into account
factors including, but not limited to: (1)
The country’s cooperation with respect
to issuance of travel documents for
citizens, subjects, nationals, and
residents of that country who are subject
to a final order of removal; (2) the
number of final and unexecuted orders
SUMMARY:
E:\FR\FM\18JAN1.SGM
18JAN1
Agencies
[Federal Register Volume 76, Number 11 (Tuesday, January 18, 2011)]
[Notices]
[Pages 2914-2915]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Oral Microbiology.
Date: January 27-28, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: Baljit S. Moonga, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214, MSC 7806, Bethesda, MD
20892, 301-435-1777, moongabs@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
[[Page 2915]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Risk Prevention and Health Behavior.
Date: February 2, 2011.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call.)
Contact Person: Claire E. Gutkin, PhD, MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3106, MSC 7808, Bethesda, MD
20892, 301-594-3139, gutkincl@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Molecular Neuropharmacology
and Signaling Study Section.
Date: February 7-8, 2011.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Deborah L. Lewis, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-408-9129, lewisdeb@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Biology Development and Disease
Study Section.
Date: February 9-10, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Delfina, 530 West Pico Boulevard, Santa Monica,
CA 90405.
Contact Person: Priscilla B. Chen, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4104, MSC 7814, Bethesda, MD
20892, (301) 435-1787. chenp@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Cellular and Molecular Biology
of Neurodegeneration Study Section.
Date: February 9-10, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco, 501 Geary Street, San Francisco, CA 94102.
Contact Person: Laurent Taupenot, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-435-1203. taupenol@csr.nih.gov.
Name of Committee: Immunology Integrated Review Group; Innate
Immunity and Inflammation Study Section.
Date: February 10-11, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Guest Suites Santa Monica Hotel, 1707 Fourth
Street, Santa Monica, CA 90401.
Contact Person: Tina McIntyre, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892. 301-594-
6375. mcintyrt@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Host Interactions with Bacterial Pathogens
Study Section.
Date: February 11, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Marina del Rey Hotel, 13534 Bali Way, Marina del Rey, CA
90292.
Contact Person: Fouad A El-Zaatari, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD
20892. (301) 435-1149. elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR08-130: International Research in Infectious Diseases
including AIDS (IRIDA).
Date: February 11, 2011.
Time: 1 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Marina del Rey Hotel, 1354 Bali Way, Marina del Rey, CA
90292.
Contact Person: Soheyla Saadi, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3211, MSC 7808, Bethesda, MD 20892. 301-435-
0903. saadisoh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative: Cardiovascular Disease and Epidemiology.
Date: February 11, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: J Scott Osborne, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD 20892. (301) 435-
1782. osbornes@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 11, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-871 Filed 1-14-11; 8:45 am]
BILLING CODE 4140-01-P